Cardio Pharm & Valvular Dz Flashcards

1
Q

Four main goals of treating heart disease

A

1) Relieving congestion
2) Improving cardiac pump function (systolic function)
3) Promoting forward flow = vasodilation
4) Reducing the amount of work on the heart = vasodilation and decrease SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the cause of congestion with heart failure?

A

Result of excessively increased venous pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical signs of right CHF

A

+ Ascites
+ Jugular distension
+ Pleural effusion in cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical sign of left CHF

A

+ Coughing associated with pulmonary edema

+/- Pleural effusion in cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Three main goals with dogs with acute CHF therapy

A

1) Relieve congestion
2) Improve oxygenation
3) Improve cardiac output (systolic function) by increasing pump function and promoting forward flow (vasodilation)
* Problem pushing the blood forward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Three main goals with cats with acute CHF therapy

A

1) Improve congestion (pulmonary edema and pleural effusion)
2) Improve oxygenation
3) Improve ventricular function = filling (diastole) and contraction (systole)
* Problem with ventricular relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which species (dogs or cats) do we want to diagnose the underlying disease with acute CHF?

A

Dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Three interventions for acute CHF

A

> > FOP

1) Furosemide
2) Oxygen
3) Pimobendan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA, route of admin, frequency of admin, and duration of effect of furosemide

A

> MOA = loop diuretic
Route = any, depends on the severity of the presentation
Duration = up to 8 hours
Frequency = patient dependent, based on respiratory rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the number one indicator/clinical sign that pulmonary edema is worsening?

A

Increasing respiratory rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What things do we want to continually monitor with furosemide use? (3)

A

1) Urine production
2) Electrolyte values
3) Renal values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Signs that you’ve excessively dosed an animal with furosemide (5)

A

1) Dehydration
2) Electrolyte abnormalities
3) Low cardiac output = increased CRT, weak to absent femoral pulses
4) Renal failure = azotemia
5) Hypochloremic metabolic alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the one thing you DON’T want to do when administering oxygen to the patient?

A

Stress the patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA and effects of pimobendan

A

> INODILATOR
- Ca++ sensitizer and phosphodiesterase inhibitor (increases the amount of Ca++ available)
+ Positive inotrope = increases contractility of the heart
+ Vasodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What side effects do we see with pimobendan?

A

RARELY GI upset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hydrazaline - what do we use it for and what does it do?

A

> Potent arterial vasodilator

- Used with MODERATE acute CHF cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Side effects of hydrazaline use

A

Hypotension and a reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What vasodilator do we use with severe CHF?

A

> Nitroprusside = potent mixed vasodilator

- Short half life = needs to be administered IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Specific administration issue and side effects with nitroprusside

A
  • Turns to cyanide = needs to be covered from light exposure

- Side effect = hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When do we use dobutamine? What does it do?

A

> SEVERE CHF = when you may not have enough time for pimobendan to start working

  • MOA = B-1 (positive inotrope) and A-1 agonist
  • Minimal B-2 activity
  • Short half life = needs to go IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Side effect of dobutamine use

A

Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What therapeutic procedure do we often have to do with cats with CHF?

A

> Thoracocentesis, to drain the pleural effusion

*Isn’t effectively dealt with with diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What sedative is helpful for nervous/stressed animals in CHF?

A

Butorphanol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What can happen with cats that have CHF?

A

Hypothermia - may need to warm them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Is FOP for acute CHF used for both dogs and cats?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Triple and quadruple therapy for treating chronic CHF

A

1) Furosemide
2) ACE inhibitor - enalpril
3) Pimobendan
4) Spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Three effects of ACE inhibitor use

A

1) Inhibits Na+/water retention by decreasing aldosterone production
2) Cause vasodilation (helps block the RAAS activation due to dehydration)
3) Decreases remodeling (fibrosis and scarring of vasculature and the myocardium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Side effects of ACE inhibitor use

A

1) Hyperkalemia
2) Renal insufficiency
3) Hypovolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which are potent vasodilators - hydrazaline, nitroprusside, or ACE inhibitors?

A

1) Most potent = nitroprusside
2) Hydrazaline
3) Least potent = ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What type of patient do we NOT want to administer diuretics and ACE inhibitors? Why?

A

> > DEHYDRATED patients = vasoconstricting the efferent arteriole of the kidney + dehydration/hypovolemia = double decrease in GFR = can cause renal failure
- Administer them once they’re drinking or rehydrated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Is pimobendan contraindicated in cats with HCM?

A

No - improves diastolic (and systolic) function = improve filling of ventricles, decreases right atrial pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

MOA, effects, and side effects of spironolactone

A

> MOA = aldosterone antagonist

  • Prevents myocardial fibrosis
  • Decreases Na/water retention
  • K+ sparing
  • Side effects = hyperkalemia
33
Q

Is spironolactone a diuretic?

A

NOT REALLY

34
Q

What do we do if the CHF is progressing or becoming more severe? (3)

A

1) Increase furosemide dose
2) Increase frequency of furosemide dose
3) Change route of admin of furosemide from oral –> SQ (more bioavailable)

35
Q

What two situations do we treat supraventricular arrhythmias?

A

1) Animals displaying clinical signs as a consequence of the arrhythmias
2) Evidence of hemodynamic compromise = poor BP due to high HR or compromised CO

36
Q

What three drugs do we use to treat supraventricular arrhythmias? What is our goal with treatment?

A

1) Ca++ channel blocker (diltiazem)
2) Beta blocker
3) Digoxin
» SLOW AV NODAL CONDUCTION TIME

37
Q

What two anti-arrhythmics do we not use in combo?

A

Beta blockers and Ca++ channel blockers

38
Q

Diltiazem MOA and effect

A

> Specific Ca++ channel blocker that works on the heart

  • Negative inotrope
  • Negative chronotrope (decrease HR)
  • Decreases AV nodal conduction time
  • Quick onset action
39
Q

Which anti-arrhythmic do we not use in patients with CHF?

A

Beta blockers

40
Q

MOA and effects of beta blockers

A
  • NOT safe with CHF
  • Negative inotrope, chronotrope (HR), lusitrope (relaxation)
  • Tx supraventricular tachycardia
  • Don’t use with diltiazem
41
Q

Side effects of beta blockers (4)

A

1) Hyperkalemia
2) Lethargy
3) Anorexia
4) Bradycardia

42
Q

MOA and effect of digoxin

A

> MOA = Na/K/ATPase inhibitor, parasympathomimetic

  • Takes 5 days to achieve levels = not for acute cases
  • Weak positive inotrope
  • Negative chronotrope
  • Narrow therapeutic range
43
Q

Common side effects of digoxin

A

GI toxicity - not for patients who aren’t eating

44
Q

What happens with digoxin with renal disease and hypokalemia?

A

Digoxin levels increase

45
Q

When do we treat ventricular arrhythmias (3)?

A

1) Patient is displaying clinical signs, Ex: syncope, low BP
2) Evidence of hemodynamic compromise
3) Risk of sudden death

46
Q

What do we use to treat ventricular arrhythmias acutely?

A

Lidocaine IV - bolus and CRI

47
Q

What can affect the efficacy of lidocaine?

A

K+ levels = if it’s too low, it won’t work

48
Q

Toxic side effects of lidocaine (3)

A
  • Nausea
  • Vomiting
  • Seizures
49
Q

What do we use to treat ventricular arrhythmias chronically in dogs? (2)

A

1) Melexitine - oral form of lidocaine

2) Sotalol - beta blocker = class III anti-arrhythmic

50
Q

What do we use to treat ventricular arrhythmias chronically in cats?

A

Beta blockers - sotalol or atenolol

51
Q

When do we treat bradyarrhythmias (3)?

A

1) Syncope
2) CHF = heart rate is too persistently slow
3) Hemodynamic compromise

52
Q

How do we treat bradyarrhythmias?

A

Place a pacemaker

53
Q

What ECG abnormalities do we see with mitral and tricuspid regurgitation?

A

Tall and/or wide P waves due to atrial enlargement

54
Q

What does tall R waves indicate on ECG?

A

Left ventricular hypertrophy

55
Q

What type of arrhythmias are common with valvular disease?

A

Supraventricular arrhythmias - narrow QRS complexes

56
Q

At what point in the cardiac cycle do we hear mitral/tricuspid regurgitation murmurs?

A

Systole

57
Q

Differential diagnoses for mitral valve regurgitation (5)

A

1) Chronic/degenerative mitral valve disease
2) Dilated cardiomyopathy and stretching of the valve
3) Vegetative endocarditis
4) Congenital mitral dysplasia
5) Secondary to hypertension

58
Q

Gross pathologic findings of endocardiosis or degenerative valve disease

A
  • Diffuse thickening of the valve
  • Thickening of chordae tendinae, may stretch or rupture
  • SMOOTH surface to the valves
  • Curling of the valve leaflets
  • Ventricular dilation and atrial enlargement based on regurgitated blood flow
  • Tears in the atrial endocardial surface
59
Q

Why do we see vasoconstriction and Na+/water retention with AV valve regurgitation?

A

Reduction of forward flow = slight hypotension = neurohormonal activation = activation of the RAAS

60
Q

Reasons for cough with AV regurgitation

A
  • Atrial enlargement and bronchial compression

- Atrial enlargement = increased pressure = left CHF

61
Q

Why do we see arrhythmias with AV valve regurgitation?

A

Atrial stretch = fibrosis = arrhythmias

62
Q

Diagnostics for valvular disease

A
  • History: cough, small breed and middle aged dogs
  • PE = auscult murmur
  • Thoracic rads
  • Echocardiography
  • Arrhythmias on ECG
    +/- Systemic complications found on CBC and chem = renal and lyte values
63
Q

Why may we see jugular pulsation with valvular disease?

A

Tricuspid valve regurgitation

64
Q

When do we treat valvular disease (4)?

A

1) When CO is compromised, Ex: signs of hypotension, > 1/3 abnormal or premature complexes
2) Evidence of CHF
3) Electrically stable - ventricular arrhythmias
4) Underlying disease associated with sudden death, Ex: v-tach

65
Q

Is systolic function compromised with valvular disease?

A

No - may be dilated but is still able to contract adequately

66
Q

Goals of mitral regurgitation therapy (3)

A

> > Reduce left atrial size
1) Cause diuresis to reduce LA pressure on bronchi with ACE-I and furosemide
2) Decrease BP and encourage forward flow with ACE-I and vasodilators (amlodipine, hydralazine)
+/- With CHF = add pimobendan to increase systolic function and vasodilation

67
Q

What anti-arrhythmic therapies do we use with valvular disease? (2)

A
  • Without atrial enlargement of CHF = beta and Ca++ channel blockers
  • With significant atrial enlargement or CHF = digoxin or digoxin+diltiazem (Ca++ channel blocker)
68
Q

Clinical signs that help differentiate endocarditis from endocardiosis (3)

A

1) NEW murmur with no previous history of heart disease
2) Fever
3) Signs of systemic involvement, Ex: joint pain, moist cough, lethargy, anemia

69
Q

What valves are most commonly affected with canine endocarditis?

A

Mitral and aortic valves

70
Q

What type of dog is most commonly affected by endocarditis?

A

Larger breed dogs

71
Q

How does the animal contract endocarditis?

A

1) Stems from a previous wound or infection, Ex: mouth with stems, skin wound, pneumonia, GI , urogenital tract
2) Roughened endocardial surface causes platelet aggregation around the bacteria on the valve
3) Has the ability to embolize and spread bacteria

72
Q

Most common etiologic agents with endocarditis (4)

A

1) Staph aureus
2) E. coli
3) Beta-hemolytic Strep (common with pneumonia)
4) Rarely fungal in immunocompromised animals

73
Q

Differences between endocarditis and endocardiosis on gross lesions

A
  • Valve edges are ROUGH with endocarditis

- Endocardiosis or degenerative valve disease = valves are SMOOTH

74
Q

Clinical outcomes of endocarditis patients (6)

A

1) Death from septicemia
2) Valvular insufficiency (both AV and semilunar)
3) Valvular stenosis (semilunar)
4) R or L CHF
5) Thromboembolic events to the liver, spleen, brain, extremities, or myocardium
6) Other disorders = DIC, sterile polyarthritis

75
Q

What two types of arrhythmias do we see with endocarditis?

A
  • Ventricular arrhythmias because of sepsis and chemical mediators
  • Heart block = aortic node is near to the AV valves, can erode nearby
76
Q

How do we definitively diagnose endocarditis? (3)

A

1) Blood cultures
2) Echocardiography
3) Urine cultures = may help if there’s low concentration in the blood

77
Q

General goals of endocarditis therapy (4)

A

1) Treat life-threatening problems first, Ex: sepsis, arrhythmias, CHF
2) Treat bacteria infections
3) Treat chronic valvular disease and CHF
4) Supportive care

78
Q

What spectrum, concentration, route, duration, and cidal/static properties do we need with antimicrobial use with endocarditis?

A
  • BROAD spectrum = need to cover gram +/-
  • Bacteriocidal with sepsis
  • HIGH concentrations delivered parenterally for the first 5-10 days
  • LONG duration = at least 4 weeks
  • Adjust if needed, after starting empirical treatment, after getting the C&S results